| License: Creative Commons Attribution 3.0 PDF - Published Version (532kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-454145
- DOI to cite this document:
- 10.5283/epub.45414
Abstract
Background and Objectives Hyperthermic intrathoracic chemotherapy (HITOC) is used for the treatment of malignant pleural tumors. Although HITOC proved to be safe, postoperative renal failure due to nephrotoxicity of intrapleural cisplatin remains a concern. Methods This single-center study was performed retrospectively in patients who underwent pleural tumor resection and HITOC between September ...

Owner only: item control page